Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

512
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
512
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.5K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

605
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
605
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

567
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

813
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

568
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
568

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful long-term systemic sclerosis treatment by high-frequent low-dose B cell-depleting therapy.

Journal of autoimmunity·2024
Same author

Determination of blood loss in bimaxillary surgery: does the formula and the time point affect results?

International journal of oral and maxillofacial surgery·2021
Same author

Tuberculosis sepsis after tocilizumab treatment.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

Microstructural analysis of subchondral bone in knee osteoarthritis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Ventilation time and prognosis after stroke thrombectomy: the shorter, the better!

European journal of neurology·2020
Same author

End-of-life decision making by Austrian physicians - a cross-sectional study.

BMC palliative care·2020

Related Experiment Video

Updated: Mar 18, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.6K

COPART Risk Score, Endothelial Dysfunction, and Arterial Hypertension are Independent Risk Factors for Mortality in

G Hackl1, P Jud1, A Avian2

  • 1Department of Internal Medicine, Division of Angiology, Medical University Graz, Austria.

European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|July 3, 2016
PubMed
Summary

The COPART risk score and flow-mediated dilation (FMD) predict mortality in peripheral artery disease patients. Combining these with arterial hypertension offers the best long-term survival assessment for claudicants.

Keywords:
Arterial hypertensionCOPART risk scoreFlow mediated dilationMortalityPAOD

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

28.1K

Related Experiment Videos

Last Updated: Mar 18, 2026

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

44.6K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.9K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

28.1K

Area of Science:

  • Vascular Medicine
  • Cardiovascular Research
  • Clinical Prognostics

Background:

  • Peripheral artery disease (PAOD) significantly impacts patient prognosis.
  • The COPART risk score is a tool for assessing PAOD patient outcomes.
  • Endothelial function, measured by flow-mediated dilation (FMD), is crucial for vascular health.

Purpose of the Study:

  • To evaluate the long-term mortality prediction capabilities of the COPART risk score and FMD in patients with intermittent claudication.
  • To determine the combined predictive value of these markers for disease-specific survival.

Main Methods:

  • A prospective observational study included 184 claudicants with a median follow-up of 7.9 years.
  • Brachial FMD was measured at study inclusion to assess endothelial function.
  • Patients were stratified into low, medium, and high risk groups based on the COPART risk score.

Main Results:

  • Overall survival rates significantly differed across COPART risk score groups (p < .001).
  • Survivors exhibited significantly better FMD compared to non-survivors (p < .001).
  • COPART risk score, FMD (≤2.5 vs. >2.5), and arterial hypertension were identified as independent predictors of long-term mortality.

Conclusions:

  • The COPART risk score, FMD, and arterial hypertension are significant independent predictors of long-term mortality in claudicants.
  • Integrating these three factors provides the most accurate mortality assessment for this patient group.
  • These findings support the use of a multi-factor approach for predicting long-term outcomes in PAOD.